Come up with a name for your new list and we'll add to it:
Simcere Pharmaceutical Group raised a round of funding on December 23, 2013. Investors include
Management Buyout (MBO).
Simcere Pharmaceutical Group (NYSE: SCR) is a pharmaceutical company specializing in the development, manufacturing, and marketing of branded pharmaceuticals in China. Simcere concentrates its researc…